This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Mirena Banner

Mirena® (52mg Intrauterine Delivery System Levonorgestrel)

Guidelines

Mirena® is recommended as a first line treatment option in idiopathic Heavy Menstrual Bleeding (HMB)

NICE Guidelines booklet

NICE Guidance:

NICE recommends a levonorgestrel-releasing (LNG) IUS, like Mirena, as a first-line option for heavy menstrual bleeding (HMB).​

Read the latest NICE clinical guidance on Heavy menstrual bleeding: assessment and management (2018)

VIEW GUIDANCE
Mirena Product Content Card
Mirena® (52mg levonorgestrel) Intrauterine System
Learn more about Mirena®.
PP-MIR-IE-0069-1, January 2026
arrow_forward
Mirena Product Content Card
Mirena® (52mg levonorgestrel) | Mechanism of Action
Learn more about the mechanism of action of Mirena®
PP-MIR-IE-0070-1, January 2026
arrow_forward
Mirena Product Content Card
Mirena® (52mg levonorgestrel | Insertion and Removal
Learn more about the insertion and removal of Mirena®
PP-MIR-IE-0071-1, January 2026
arrow_forward

PP-MIR-IE-0072-1   |   January 2026

    • 1
      Mirena® (52 mg intrauterine delivery system levonorgestrel): Summary of Product Characteristics.
    • 2
      NICE guideline NG88. Heavy menstrual bleeding: assessment and management (November 2018). Available at: https://www.nice.org.uk/guidance/ng88